Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYApollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101PREV STORYMarius Pharmaceuticals Announces Issuance of Two Key Patents Protecting its Proprietary Oral Testosterone Therapy